Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.68 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.68 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.68 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.68 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.68 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.63 |
| ▸ | CHRNG | P07510 | 1/20 | 0.63 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.63 |
| ▸ | CHRND | Q07001 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2437188 | 1.00 | CHRNB2 (0.68) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 | |
| SCHEMBL7407230 | 1.00 | CHRNB2 (0.68) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 | |
| Hydrochloric Acid SCHEMBL7460292 | 0.98 | CHRNB2 (0.66) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 | |
| SCHEMBL905220 | 0.89 | CHRNA3 (0.70) | CHRNB2CHRNA4CHRNA3 | |
| SCHEMBL905218 | 0.89 | CHRNA3 (0.70) | CHRNB2CHRNA4CHRNA3 | |
| Hydrochloric Acid SCHEMBL7839311 | 0.88 | CHRNA3 (0.68) | CHRNB2CHRNA4CHRNA3 | |
| Hydrochloric Acid SCHEMBL7842121 | 0.88 | CHRNA3 (0.68) | CHRNB2CHRNA4CHRNA3 | |
| SCHEMBL23498464 | 0.82 | CHRNB2 (0.69) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 | |
| SCHEMBL4651869 | 0.82 | CHRNB2 (0.69) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 | |
| SCHEMBL8437911 | 0.82 | CHRNB2 (0.69) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180161329-A1 | PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | TEIJIN PHARMA LIMITED (JP) | 2018-06-14 | — | — | US | disclosed |
| US-6288055-B1 | NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS; PYRIDINE DERIVATIVES LINKED BY LIGAND | ADVANCED MEDICINE, INC. | 2001-09-11 | — | — | US | disclosed |
| EP-1083917-A1 | NOVEL ANALGESIC AGENTS | Advanced Medicine, Inc. (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999064038-A9 | NOVEL ANALGESIC AGENTS | ADVANCED MEDICINE INC (US) | 2000-05-04 | — | — | WO | disclosed |
| WO-1999064038-A1 | NOVEL ANALGESIC AGENTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180161329-A1 | PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | CDK4, CDK6, CDK16 | CHRNB2 4863/4885CHRNA4 4628/4885CHRNA3 4715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.